Physician
Huntington Hospital Association
Huntington Hospital Association was paid $3.08M by Medicaid between Aug 2019 and Nov 2024, across 69 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoHUNTINGTON HOSPITAL ASSOCIATION
HUNTINGTON, NY 11743
HUNTINGTON, NY 11743
33aNPI1225003221assigned 02/22/2006
33bProvider typeCardiovascular Disease Physician
28Total paid$3.08M
24GClaims78,615
24DCodes billed69
24AFirst – last monthAug 2019 – Nov 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in New York
Rank by total paid#26 of 1,564
Median peer was paid$13K
This provider vs. median237×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 2,933 | $120K | |
| 2020 | 9,688 | $456K | |
| 2021 | 16,386 | $626K | |
| 2022 | 17,452 | $664K | |
| 2023 | 18,417 | $677K | |
| 2024incomplete | 13,739 | $540K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 3,663 | 3,507 | $652K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 3,794 | 3,562 | $641K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 2,390 | 2,265 | $384K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.1% | 750 | 726 | $219K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.4% | 643 | 620 | $197K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.8% | 706 | 675 | $148K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.4% | 768 | 756 | $137K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.4% | 2,675 | 2,487 | $134K |
| 80053 | Comprehensive metabolic panel | 4.0% | 5,015 | 4,586 | $125K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.6% | 1,181 | 1,151 | $80K |
| 86901 | 1.4% | 1,379 | 1,350 | $44K | |
| 86850 | 1.4% | 1,381 | 1,353 | $43K |
57 more codes
| 36415 | Collection of venous blood by venipuncture | 1.4% | 6,552 | $43K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.3% | 1,121 | $41K |
| 86900 | 1.0% | 1,381 | $31K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,713 | $27K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,089 | $25K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 527 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 85 | $24K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,827 | $13K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 29 | $9K |
| 36000 | <1% | 132 | $5K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 643 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 190 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,610 | $3K |
| J3490 | Unclassified drugs | <1% | 924 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,322 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 150 | $3K |
| 83880 | <1% | 77 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,995 | $2K |
| 81025 | <1% | 474 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,686 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 865 | $1K |
| 85730 | <1% | 1,809 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,874 | $1K |
| 87631 | <1% | 13 | $855.01 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 66 | $838.68 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,374 | $649.19 |
| 85610 | <1% | 1,785 | $544.97 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 38 | $494.32 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 151 | $466.99 |
| 81001 | <1% | 2,206 | $446.03 | |
| 82962 | <1% | 438 | $412.48 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,627 | $396.49 |
| 81003 | <1% | 714 | $377.47 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 246 | $349.61 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 247 | $338.46 |
| J2704 | Injection, propofol, 10 mg | <1% | 103 | $309.54 |
| 85027 | <1% | 72 | $295.92 | |
| 0225U | <1% | 504 | $292.52 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,648 | $263.87 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,008 | $174.58 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 15 | $142.63 |
| 84702 | <1% | 1,196 | $114.29 | |
| 83735 | <1% | 789 | $113.33 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 67 | $106.81 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 55 | $61.77 |
| 83690 | <1% | 1,672 | $50.14 | |
| 84484 | <1% | 1,536 | $43.44 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 12 | $41.75 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 29 | $26.40 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $15.80 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 15 | $7.61 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 0% | 37 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 12 | $0.00 |
| 83605 | 0% | 230 | $0.00 | |
| 85379 | 0% | 198 | $0.00 | |
| 87040 | 0% | 53 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFAGAN, MICHAEL (CFO)
| Provider | Location | Paid |
|---|---|---|
| Huntington Hospital Association | Huntington, NY | $6K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.